ertiprotafib has been researched along with Obesity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bombrun, A; Hooft van Huijsduijnen, R; Sauer, WH; Swinnen, D | 1 |
Bhattarai, BR; Chang, KJ; Cho, H; Lee, KH; Shrestha, S | 1 |
1 review(s) available for ertiprotafib and Obesity
Article | Year |
---|---|
Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs.
Topics: Animals; Diabetes Mellitus, Type 2; Glucose; Humans; Hypoglycemic Agents; Obesity; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases | 2004 |
1 other study(ies) available for ertiprotafib and Obesity
Article | Year |
---|---|
Methylenedisalicylic acid derivatives: new PTP1B inhibitors that confer resistance to diet-induced obesity.
Topics: Adipocytes; Animals; Anti-Obesity Agents; Diet; Disease Models, Animal; Mice; Mice, Inbred C57BL; Obesity; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Salicylates; Weight Gain | 2007 |